Nursing: Emerging Infectious Diseases: A World View
15.00
About the Course
Although we have all considered the potential impact of emerging infectious disease, the world’s current battle with COVID-19 is shifting the hypothetical into a reality, impacting each global citizen. At the root are a variety of infectious pathogens, some representing a resultant disease and each featuring varying abilities to pass between people. In addition to bugs that have wreaked havoc for centuries (e.g., Yersinia pestis: the Plague), in excess of 40 novel infectious diseases have appeared in the past 50 years (e.g., MERS, COVID-19).
Learning Outcomes
Upon completion of this course, the learner will be able to:
Bradley Gillespie, PharmD, trained as a clinical pharmacist, has practiced in an industrial setting for the past 20+ years. His initial role was as a Clinical Pharmacology and Biopharmaceutics reviewer at the U.S. Food and Drug Administration (FDA), followed by 15 years of leading early development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist and enjoys mentoring drug development scientists and health professionals, leading workshops, and developing continuing education programs for pharmacy, nursing, and other medical professionals.
Disclosures:
Resolution of Conflict of Interest
Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.
Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
©2022: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
Course ID: 35030
Although we have all considered the potential impact of emerging infectious disease, the world’s current battle with COVID-19 is shifting the hypothetical into a reality, impacting each global citizen. At the root are a variety of infectious pathogens, some representing a resultant disease and each featuring varying abilities to pass between people. In addition to bugs that have wreaked havoc for centuries (e.g., Yersinia pestis: the Plague), in excess of 40 novel infectious diseases have appeared in the past 50 years (e.g., MERS, COVID-19).
Learning Outcomes
Upon completion of this course, the learner will be able to:
- Describe two ways that infectious diseases spread.
- Name one event required to allow an emerging infectious disease to become established.
- Distinguish: endemic versus epidemic versus pandemic.
- Understand how the basic reproduction number relates to disease transmissibility.
- Discuss the re-emergence of at least one infectious disease thought to be contained.
- Identify three key practices for preventing infectious disease.
- Appreciate the effect of herd immunity.
Bradley Gillespie, PharmD, trained as a clinical pharmacist, has practiced in an industrial setting for the past 20+ years. His initial role was as a Clinical Pharmacology and Biopharmaceutics reviewer at the U.S. Food and Drug Administration (FDA), followed by 15 years of leading early development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist and enjoys mentoring drug development scientists and health professionals, leading workshops, and developing continuing education programs for pharmacy, nursing, and other medical professionals.
Disclosures:
Resolution of Conflict of Interest
Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.
Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
©2022: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
Course ID: 35030
View Requirements
Want Unlimited CE? Become a Member
Emerging Infectious Diseases: A World View
15.00
About the Course
Although we have all considered the potential impact of emerging infectious disease, the world’s current battle with COVID-19 is shifting the hypothetical into a reality, impacting each global citizen. At the root are a variety of infectious pathogens, some representing a resultant disease and each featuring varying abilities to pass between people. In addition to bugs that have wreaked havoc for centuries (e.g., Yersinia pestis: the Plague), in excess of 40 novel infectious diseases have appeared in the past 50 years (e.g., MERS, COVID-19).
Learning Outcomes
Upon completion of this course, the learner will be able to:
Bradley Gillespie, PharmD, trained as a clinical pharmacist, has practiced in an industrial setting for the past 20+ years. His initial role was as a Clinical Pharmacology and Biopharmaceutics reviewer at the U.S. Food and Drug Administration (FDA), followed by 15 years of leading early development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist and enjoys mentoring drug development scientists and health professionals, leading workshops, and developing continuing education programs for pharmacy, nursing, and other medical professionals.
Disclosures:
Resolution of Conflict of Interest
Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.
Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
©2022: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
Course ID: 35030
Although we have all considered the potential impact of emerging infectious disease, the world’s current battle with COVID-19 is shifting the hypothetical into a reality, impacting each global citizen. At the root are a variety of infectious pathogens, some representing a resultant disease and each featuring varying abilities to pass between people. In addition to bugs that have wreaked havoc for centuries (e.g., Yersinia pestis: the Plague), in excess of 40 novel infectious diseases have appeared in the past 50 years (e.g., MERS, COVID-19).
Learning Outcomes
Upon completion of this course, the learner will be able to:
- Describe two ways that infectious diseases spread.
- Name one event required to allow an emerging infectious disease to become established.
- Distinguish: endemic versus epidemic versus pandemic.
- Understand how the basic reproduction number relates to disease transmissibility.
- Discuss the re-emergence of at least one infectious disease thought to be contained.
- Identify three key practices for preventing infectious disease.
- Appreciate the effect of herd immunity.
Bradley Gillespie, PharmD, trained as a clinical pharmacist, has practiced in an industrial setting for the past 20+ years. His initial role was as a Clinical Pharmacology and Biopharmaceutics reviewer at the U.S. Food and Drug Administration (FDA), followed by 15 years of leading early development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist and enjoys mentoring drug development scientists and health professionals, leading workshops, and developing continuing education programs for pharmacy, nursing, and other medical professionals.
Disclosures:
Resolution of Conflict of Interest
Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.
Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
©2022: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
Course ID: 35030